Skip to main content
. 2023 Jan 10;15(2):438. doi: 10.3390/cancers15020438

Figure 9.

Figure 9

Overall survival curves according to 2022 ELN risk classification and Tazi et al. [2] genomic AML classification: (A) Favorable, (B) Intermediate and (C) Adverse risk groups.